Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression
Authors:
- 23 July 2007
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 46 (10) , 936-949
Abstract
Neuroblastoma is a heterogeneous neoplasm that has served as a paradigm for the clinical utility of somatically acquired genomic aberrations. DNA copy number alterations (CNA) are currently used to predict prognosis, including MYCN amplification and deletions at chromosome bands 1p36 and 11q23. We predicted that genome‐wide assessment of DNA aberrations in neuroblastoma tumors would provide a more precise estimation of clinical phenotype, and could be used to predict outcome. We measured CNAs in a representative set of 82 diagnostic tumors on a customized high‐resolution BAC array‐based CGH platform supplemented with additional clones across 1p36, 2p24, 3p21‐22, 11q14‐24, and 16p12‐13, and integrated these data with RNA expression data. We used an unbiased statistical method to define a set of minimal common regions (MCRs) of aberration. Unsupervised hierarchical clustering identified four distinct genomic subclasses. First, a subset of tumors with a clinically benign phenotype showed predominantly whole chromosome gains and losses. Second, tumors with MYCN amplification had a unique genomic signature of 1p deletion and 17q gain, but few other rearrangements. Third, tumors with an aggressive clinical phenotype without MYCN amplification, showed multiple structural rearrangements. Most notable were deletions of 3p, 4p, and 11q and gain of 1q, 2p, 12q, and 17q. Lastly, there was a subset of tumors with an aggressive clinical phenotype and no detectable DNA CNAs. The genomic subsets were highly correlated with patient outcome, and individual MCRs remained prognostic in a multivariable model. DNA signature patterns embed important prognostic information in diagnostic neuroblastoma samples, and can identify candidate cancer‐related genes.Keywords
This publication has 32 references indexed in Scilit:
- Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism ArraysPLOS ONE, 2007
- CHD5 Is a Tumor Suppressor at Human 1p36Cell, 2007
- STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experimentsGenome Research, 2006
- Chromosome 1p and 11q Deletions and Outcome in NeuroblastomaNew England Journal of Medicine, 2005
- Gene amplifications in osteosarcoma—CGH microarray analysisGenes, Chromosomes and Cancer, 2004
- cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastomaBMC Genomics, 2004
- 1-Mb Resolution Array-Based Comparative Genomic Hybridization Using a BAC Clone Set Optimized for Cancer Gene AnalysisGenome Research, 2003
- Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemiaSeminars in Hematology, 2000
- Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasOncogene, 1999
- Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1991